Product Code: ETC338495 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Australia Pharmaceuticals Market could see a tapering of growth rates over 2025 to 2029. Starting high at 5.40% in 2025, the market steadily declines to 4.41% by 2029.
The Australia pharmaceuticals market is one of the most advanced and well-regulated markets in the world. It has grown rapidly over the past decade, driven by a number of factors such as an ageing population, rising healthcare costs, technological advances and government incentives for research & development (R&D) activities. The market is expected to register a CAGR of around 7% over the forecast period 2021???2026.
Aging Population - Australia aging population is driving growth in demand for drugs that treat age-related conditions such as arthritis, diabetes and heart disease. Increasing Healthcare Expenditure ??? Government expenditure on healthcare services is growing steadily due to various initiatives taken by different stakeholders including governments, private insurance companies and health funds. This leads to increased spending on drugs which fuel growth in the pharmaceuticals industry in Australia. Technological Advancements ??? The introduction of new technologies into drug production processes have enabled manufacturers to produce more efficient drugs at lower costs which help stimulate demand for their products.
Cost pressures from PBMs - Pharmaceutical Benefit Managers (PBMs) are increasingly seeking discounts or rebates from pharmaceutical companies when buying large volumes of medicines which reduce their profits margins significantly. Regulatory Environment ??? The tight regulatory environment imposed by AHPRA means that drug developers must meet stringent standards before they can be approved for sale in Australia and this increases cost pressure on manufacturers.
Major players operating within the Australian pharma space include AstraZeneca Pty Ltd., Sanofi Aus Pty Ltd., Pfizer Australia Pty Ltd., GlaxoSmithKline Australasia Holdings Pty Ltd., AbbVie PTY LTD , Johnson & Johnson Pacific PTY LTD , Bayer Austalia Limited etc.
The pandemic has affected all industries across the globe but it has had particularly severe implications for those working within medical sectors like healthcare technology and biopharma industries due to disruptions caused by lockdowns leading many companies having difficulty obtaining raw materials supplies . Additionally , investments made towards R&D activities have been reduced during 2020 resultingin a slowdownin innovation activity relatedto novel treatments/ medications .
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pharmaceuticals Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pharmaceuticals Market Revenues & Volume, 2021 & 2028F |
3.3 Australia Pharmaceuticals Market - Industry Life Cycle |
3.4 Australia Pharmaceuticals Market - Porter's Five Forces |
3.5 Australia Pharmaceuticals Market Revenues & Volume Share, By Type, 2021 & 2028F |
3.6 Australia Pharmaceuticals Market Revenues & Volume Share, By Distribution Channel, 2021 & 2028F |
3.7 Australia Pharmaceuticals Market Revenues & Volume Share, By Route of Administration, 2021 & 2028F |
3.8 Australia Pharmaceuticals Market Revenues & Volume Share, By Drug Classification, 2021 & 2028F |
3.9 Australia Pharmaceuticals Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2028F |
4 Australia Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for healthcare services in Australia |
4.2.2 Growing prevalence of chronic diseases requiring pharmaceutical treatment |
4.2.3 Technological advancements leading to the development of innovative drugs |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceutical products |
4.3.2 Pricing pressure from government regulations and healthcare reimbursement policies |
5 Australia Pharmaceuticals Market Trends |
6 Australia Pharmaceuticals Market, By Types |
6.1 Australia Pharmaceuticals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Pharmaceuticals Market Revenues & Volume, By Type, 2018 - 2028F |
6.1.3 Australia Pharmaceuticals Market Revenues & Volume, By Pharmaceutical Drugs, 2018 - 2028F |
6.1.4 Australia Pharmaceuticals Market Revenues & Volume, By Biologics, 2018 - 2028F |
6.2 Australia Pharmaceuticals Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Australia Pharmaceuticals Market Revenues & Volume, By Hospital Pharmacies, 2018 - 2028F |
6.2.3 Australia Pharmaceuticals Market Revenues & Volume, By Retail Pharmacies/ Drug Stores, 2018 - 2028F |
6.2.4 Australia Pharmaceuticals Market Revenues & Volume, By Others, 2018 - 2028F |
6.3 Australia Pharmaceuticals Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Australia Pharmaceuticals Market Revenues & Volume, By Oral, 2018 - 2028F |
6.3.3 Australia Pharmaceuticals Market Revenues & Volume, By Parenteral, 2018 - 2028F |
6.3.4 Australia Pharmaceuticals Market Revenues & Volume, By Others, 2018 - 2028F |
6.4 Australia Pharmaceuticals Market, By Drug Classification |
6.4.1 Overview and Analysis |
6.4.2 Australia Pharmaceuticals Market Revenues & Volume, By Branded Drugs, 2018 - 2028F |
6.4.3 Australia Pharmaceuticals Market Revenues & Volume, By Generic Drugs, 2018 - 2028F |
6.5 Australia Pharmaceuticals Market, By Mode of Purchase |
6.5.1 Overview and Analysis |
6.5.2 Australia Pharmaceuticals Market Revenues & Volume, By Prescription-Based Drugs, 2018 - 2028F |
6.5.3 Australia Pharmaceuticals Market Revenues & Volume, By Over-The-Counter Drugs, 2018 - 2028F |
7 Australia Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Australia Pharmaceuticals Market Export to Major Countries |
7.2 Australia Pharmaceuticals Market Imports from Major Countries |
8 Australia Pharmaceuticals Market Key Performance Indicators |
8.1 Research and development investment in new drug development |
8.2 Number of patents filed for pharmaceutical products |
8.3 Adoption rate of digital health solutions in pharmaceutical companies |
8.4 Percentage of revenue allocated to marketing and promotional activities |
8.5 Rate of adoption of personalized medicine in the market |
9 Australia Pharmaceuticals Market - Opportunity Assessment |
9.1 Australia Pharmaceuticals Market Opportunity Assessment, By Type, 2021 & 2028F |
9.2 Australia Pharmaceuticals Market Opportunity Assessment, By Distribution Channel, 2021 & 2028F |
9.3 Australia Pharmaceuticals Market Opportunity Assessment, By Route of Administration, 2021 & 2028F |
9.4 Australia Pharmaceuticals Market Opportunity Assessment, By Drug Classification, 2021 & 2028F |
9.5 Australia Pharmaceuticals Market Opportunity Assessment, By Mode of Purchase, 2021 & 2028F |
10 Australia Pharmaceuticals Market - Competitive Landscape |
10.1 Australia Pharmaceuticals Market Revenue Share, By Companies, 2021 |
10.2 Australia Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |